# Supernus Pharmaceuticals, Inc. – FDA Inspection, Feb 3, 2017

Source: https://www.keypedia.com/records/fda_inspections/supernus-pharmaceuticals-inc/c2d27c0d-ba92-4fea-b2c1-e2ad08305875
Source feed: FDA_Inspections

> FDA inspection 1010922 of Supernus Pharmaceuticals, Inc., February 03, 2017. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 314. Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1010922
- Company Name: Supernus Pharmaceuticals, Inc.
- Inspection Date: 2017-02-03
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1280332 - 2025-07-31
- FDA Inspection 1109126 - 2019-10-10
- FDA Inspection 1098819 - 2019-07-10
- FDA Inspection 915034 - 2015-02-23
- FDA Inspection 888135 - 2014-06-19

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/chaltu-nwakijra/fb7fd592-2118-4547-af1e-92f61dc5ad94)
- [Company Rep](https://www.keypedia.com/people/jonathan-w-chapman/5b5134c3-71f9-4212-9429-4554d91e8aa9)

Company: https://www.keypedia.com/companies/supernus-pharmaceuticals-inc/eff1a996-667f-4888-9fd8-50ca50265d74

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c